Yukari C. Manabe - Infectious Diseases

Author Information

Yukari C. Manabe is a prominent researcher affiliated with the Infectious Diseases Institute at the Makerere College of Health Sciences, located within the Mulago Hospital Complex in Kampala, Uganda. Her research largely focuses on infectious diseases, a field in which she has made significant contributions through her extensive body of work. Her association with a leading health sciences institute underscores her commitment to advancing the understanding and treatment of infectious diseases.

Research Contributions

Yukari C. Manabe has made substantial contributions to the field of infectious diseases, with a particular focus on SARS-CoV-2, sexually transmitted infections, and HIV. Her research includes studies on the differentiation of individuals based on SARS-CoV-2 infection and vaccination status, the development of portable platforms for detecting infections, and the impact of COVID-19 on diagnostics for sexually transmitted infections. She has also explored the effects of pregnancy on immune responses during SARS-CoV-2 infection and the factors influencing the sensitivity of rapid antigen testing for COVID-19. Yukari C. Manabe's work is pivotal in improving diagnostic processes and understanding immune responses in infectious diseases.

Aliases

Yukari C. Manabe is known by several aliases in her published work, including Y. C. Manabe, Y. C. C. Manabe, Y. Manabe, and other variations of her name. These aliases reflect the different ways her name has been cited across various publications and databases.

Publication and Citation Metrics

Total Citation Count	6771
H-index	40
Total Paper Count	245

Publications:

Differentiation of Individuals Previously Infected with and Vaccinated for SARS-CoV-2 in an Inner-City Emergency Department

DOI: 10.1128/jcm.02390-21

Year: 2022

A portable magnetofluidic platform for detecting sexually transmitted infections and antimicrobial susceptibility

DOI: 10.1126/scitranslmed.abf6356

Year: 2021

Pregnancy alters IL-1β expression and anti-viral antibody responses during SARS-CoV-2 infection

DOI: 10.1016/j.ajog.2021.03.028

Year: 2021

The impact of COVID-19 pandemic on technologic and process innovation in point-of-care diagnostics for sexually transmitted infections

DOI: 10.1016/j.clinbiochem.2021.11.003

Year: 2021

Time Between Viral Loads for People with HIV during the COVID-19 Pandemic

DOI: 10.1101/2021.12.19.21268052

Year: 2021

Pregnancy alters interleukin-1 beta expression and antiviral antibody responses during severe acute respiratory syndrome coronavirus 2 infection

DOI: 10.1016/j.ajog.2021.03.028

Year: 2021

Delayed rise of oral fluid antibodies, elevated BMI, and absence of early fever correlate with longer time to SARS-CoV-2 RNA clearance in an longitudinally sampled cohort of COVID-19 outpatients

DOI: 10.1101/2021.03.02.21252420

Year: 2021

Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Status in Decedents Undergoing Forensic Postmortem Examination in Maryland, May 24 to June 30, 2020

DOI: 10.1093/ofid/ofaa611

Year: 2021

Factors that Influence the Reported Sensitivity of Rapid Antigen Testing for SARS-CoV-2

DOI: 10.3389/fmicb.2021.714242

Year: 2021

Chest X-ray interpretation does not complement Xpert MTB/RIF in diagnosis of smear-negative pulmonary tuberculosis among TB-HIV co-infected adults in a resource-limited setting

DOI: 10.1186/s12879-020-05752-7

Year: 2021

What is Dengue Hemorrhagic Fever?

How is COVID-19 Diagnosed?

How Do Pathogens Spread?

How Can Individuals and Communities Help in WHO’s Efforts?

Is There a Cure for Herpes?

What are the Symptoms of Salmonella Infection?

What are the Symptoms of Rabies?

What Are Routes of Transmission?

How are Adenovirus Infections Diagnosed?

What are the Symptoms of Schistosomiasis?

Partnered Content Networks

Relevant Topics